Learn more about Pediatrics

Pediatrics

Faster Pediatric Clinical Trials and Sales

The current regulatory climate and the need to meet FDA and EMEA requirements makes it more labor intensive for you to oversee every detail of pediatric drug research, clinical trials and sales. And, it slows you down.

Quintiles provides you with: 

  • Pediatricians, fully trained in clinical protocols and global quality standards
  • Tools, databases and information systems
  • Project management, clinical operations and regulatory and sales processes

We have managed more than 200 pediatric trials ranging from PK studies to mega trials in 33 countries. Our network has investigators in pediatric clinical trials and pediatric sub-specialties.

Specialty Care Sales Teams Deliver Revenues

After the euphoria settles from receiving regulatory approval, the business of marketing and selling moves into high gear. We can build a communication plan and develop a single or multi-country sales team. Read More about pharmaceutical commercialization.

White Paper

FDA Requirements for Clinical Studies in Pediatric Patients

FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy

Read more

White Paper

Regulations for Clinical Studies in Pediatric Patients in the European Union

After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric

Read more

Case Study

Challenging Expectations

Discover how Quintiles randomized 450 pediatric asthma patients in six months, thanks to unparalleled global coverage, experience and systems.

Learn more

Case Study

Boosting Pediatric Enrollment

Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks.

Learn more

Case Study

Propelling Pediatric Research

Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study

Learn more